ArborMed is a biopharmaceutical company committed to the development and commercialization of therapeutics for diseases with high unmet medical needs and untapped market opportunities. With operations in South Korea and US, Arbormed utilizes resources efficiently to enable "Fast to Market" development of the pipeline and US market entry. Our Demand-Driven Development (D³) approach incorporates 3 strategic pillars to build a risk-balanced pipeline: ▶Innovative new drug - starting from mid preclinical stage, develop best in class therapies with validated targets with a particular focus on rare diseases. ▶Complex generics - commercialize complex generic products with limited competition in the US that have been developed by Korean companies.
| Website | http://www.arbormed.com |
| Employees | 13 (6 on RocketReach) |
| Founded | 2017 |
| Phone | +82 2-6953-1207 |
| Technologies |
JavaScript
,
HTML
,
PHP
+4 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Biopharmaceutical, Therapeutics, Drug Development, Pharmaceutical Research, Clinical Trials, Drug Commercialization, Biotechnology, Unmet Medical Needs, Rare Diseases, Orphan Drugs, New Drug Applications, Global Health, Healthcare, Life Sciences, Pharmaceutical Manufacturing, Medical Innovation, Treatment, Research |
| Competitors | Medtronic, Boston Scientific, Smith+Nephew, Stryker, Zimmer Biomet, Johnson & Johnson, Impulse Monitoring, CRYOLIFE LIMITED, Abbott, B. Braun Group +33 more (view full list) |
Looking for a particular Arbormed employee's phone or email?
Arbormed Questions
Kyojin Park is the CEO of Arbormed.
6 people are employed at Arbormed.
Top Arbormed Employees
-
Kyojin Park
CEO at Arbormed
Seoul, KR25+ -
Manish Singhal
CBO at Arbormed
Santa Clara, CA, US31 -
1
-
Dongeun Im
Manager at Arbormed
South Korea -
Byongkeol Min
Senior Researcher at Arbormed
Yongin-si, KR1
Related Companies
